Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8759372 None

Patent 8759372 was granted and assigned to Bristol-Myers Squibb on June, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87593720

Patent Inventor Names

Chenkou Wei0

Daniel Richard Roberts0

Richard Raymond Schartman0

Date of Patent

June 24, 2014

Patent Application Number

137755280

Date Filed

February 25, 2013

Patent Citations Received

‌

US Patent 11975016 2′-substituted-N

‌

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

‌

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

‌

US Patent 11707480 Highly active compounds against COVID-19

Patent Primary Examiner

‌

Niloofar Rahmani

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8759372 None

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API